Long QT Syndrome in Children. Not One Disease Anymore**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

Journal of the American College of Cardiology

Volumn 50, Issue 14, 2007, Pages 1341-1342

  Balaji, Seshadri ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POTASSIUM CHANNEL KCNQ1; POTASSIUM CHANNEL KCNQ2;

DEFIBRILLATOR; EDITORIAL; GENE ISOLATION; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE; HUMAN; LONG QT SYNDROME; PRIORITY JOURNAL;

CHILD; DEFIBRILLATORS, IMPLANTABLE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; KCNQ1 POTASSIUM CHANNEL; LONG QT SYNDROME; MUTATION; PEDIATRICS; PRACTICE GUIDELINES; RISK ASSESSMENT;

EID: 34548814964     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.06.033     Document Type: Editorial

References (10)

1. Etheridge S.P., Sanatani S., Cohen M.I., Albaro C.A., Saarel E.V., and Bradley D.J. Long QT syndrome in children the era of implantable defibrillators. J Am Coll Cardiol 50 (2007) 1335-1340
2. Villain E., Denjoy I., Lupoglazoff J.M., et al. Low incidence of cardiac events with beta-blocking therapy in children with long QT syndrome. Eur Heart J 25 (2004) 1405-1411
3. Priori S.G., Schwartz P.J., Napolitano C., et al. Risk stratification in long QT syndrome. N Engl J Med 348 (2003) 1866-1874
4. Priori S.G., Napolitano C., Schwartz P.J., et al. Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers. JAMA 292 (2004) 1341-1344
5. Alexander M.E., Cecchin F., Walsh E.P., Triedman J.K., Bevilacqua L.M., and Berul C.I. Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics. J Cardiovasc Electrophysiol 15 (2004) 72-76
6. Cooper J.M., Stephenson E.A., Berul C.I., Walsh E.P., and Epstein L.M. Implantable cardioverter defibrillator lead complications and laser extraction in children and young adults with congenital heart disease: implications for implantation and management. J Cardiovasc Electrophysiol 14 (2003) 344-349
7. Korte T., Koditz H., Niehaus M., Paul T., and Tebbenjohanns J. High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator. Pacing Clin Electrophysiol 27 (2004) 924-932
8. Eicken A., Kolb C., Lange S., et al. Implantable cardioverter defibrillator (ICD) in children. Int J Cardiol 107 (2006) 30-35
9. Gregoratos G., Abrams J., Epstien A.E., et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarryhthmia devices-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). J Am Coll Cardiol 40 (2002) 1703-1719
10. Vyas H., Hejlik J., and Ackerman M.J. Epinephrine QT stress testing in the evaluation of congenital long-QT syndrome: diagnostic accuracy of the paradoxical QT response. Circulation 113 (2006) 1385-1392